SB
Sinopep-Allsino Biopharmaceutical Co., Ltd.
CDMO · Lianyungang, Jiangsu, China
GMP
Overview
Sinopep-Allsino supplies commercial peptide, oligonucleotide and small-molecule APIs and offers CDMO services from early development to commercial supply, with about 20-30 metric tons of annual peptide capacity. It states that it has passed four US FDA inspections since 2009. It holds active US Type II DMFs for Bivalirudin, Cetrorelix, Desmopressin, Difelikefalin, Lanreotide, Liraglutide, Octreotide, Semaglutide, Tirzepatide. The company says it sells only to qualified pharmaceutical and research organizations, not consumers.
Capabilities
- Large-scale SPPS/LPPS
- Peptide CDMO
- Generic peptide APIs
- Oligonucleotide manufacturing
- Formulation services
Quality signals
| GMP evidence | Yes |
|---|---|
| Certificates of analysis | Not found |
| Third-party testing | Not found |
| ISO certification | Not found |
| Makes own product | Yes, in-house production |